Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 23;2(6):e0000677.
doi: 10.1371/journal.pgph.0000677. eCollection 2022.

Time for a new global roadmap for supporting evidence into action

Tanja Kuchenmüller  1 , John Lavis  2 , Mehrnaz Kheirandish  3 , Ludovic Reveiz  4 , Marge Reinap  5 , Joseph Okeibunor  6 , Siswanto Siswanto  7 , Arash Rashidian  3 , Samuel Sieber  1 , Kaelan Moat  2 , Cristian Mansilla  4 , Fadi El-Jardali  8 , Matthias Helble  1 , John Reeder  1   9 , Evelina Chapman  10 , Jorge Otávio Maia Barreto  10 , Ahmed Mandil  3 , Soumya Swaminathan  11
Affiliations

Time for a new global roadmap for supporting evidence into action

Tanja Kuchenmüller et al. PLOS Glob Public Health. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

I have read the journal’s policy and the authors of this manuscript have the following competing interests: TK, MK, LR, MR, JO, SiS, AR, MH, JR, AM, SoS are employed full-time with WHO, working in the fields of research, evidence and policy. SaS and CM had consultancy contracts with WHO, supporting the organization of the WHO Global Evidence-to-Policy Summit 2021. JL chaired the group of WHO Scientific Advisors of the WHO Global Evidence-to-Policy Summit and is co-lead of the Global Commission on Evidence to Address Societal Challenges. JB and EC were serving on the Executive Committee of the WHO Global Evidence-to-Policy Summit. The authors alone are responsible for the views expressed in this paper and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.

References

    1. Kuchenmüller T, Reeder JC, Reveiz L, Tomson G, El-Jardali F, Lavis JN, et al.. COVID-19: investing in country capacity to bridge science, policy and action. BMJ Glob Health. 2021;6(2). doi: 10.1136/bmjgh-2021-005012 - DOI - PMC - PubMed
    1. Elliott JH, Turner T, Clavisi O, Thomas J, Higgins JP, Mavergames C, et al.. Living systematic reviews: an emerging opportunity to narrow the evidence-practice gap. PLoS Med. 2014;11(2):e1001603. doi: 10.1371/journal.pmed.1001603 - DOI - PMC - PubMed
    1. Pearson H. How COVID broke the evidence pipeline. Nature 2021;593:182–5. doi: 10.1038/d41586-021-01246-x - DOI - PubMed
    1. Global Commission on Evidence to Address Societal Challenges. The Evidence Commission report: A wake-up call and path forward for decisionmakers, evidence intermediaries, and impact-oriented evidence producers. Hamilton: McMaster Health Forum; 2022.
    1. Jessani N, Laurenz L, van Rooyen C, Stewart R. Evidence for decisions in the time of COVID-19: eyes on Africa. The Thinker. 2020;84(2):45–8.

LinkOut - more resources